A study to evaluate pharmacokinetic, safety, tolerability and relative bioavailability of Gepotidacin in healthy adult male and female participants

Trial Identifier: 207729
Sponsor: GlaxoSmithKline
Collaborator:
Not applicable
Start Date: March 2022
Primary Completion Date: April 2022
Study Completion Date: April 2022
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, Nevada Las Vegas, Nevada, United States, 89113